AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Calliditas Therapeutics

Major Shareholding Notification Aug 5, 2024

3020_iss_2024-08-05_899eb42d-59c3-4a30-9aed-225ff10b2934.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Calliditas Therapeutics AB

Holder

Linc AB

Instrument

Instrument Common SE0010441584
Before the transaction
Shares 5,962,312
Voting rights 5,962,312
Transaction
Reason for major shareholding notification Other
Date 31/07/2024
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction
Quantity
Shares 5,962,312
Directly held voting rights 5,962,312
Indirectly held voting rights 0
Percentage
Directly held shares 10.00722 %
Directly held voting rights 9.94698 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 9.94698 % 5,962,312
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 9.94698 % 5,962,312
Group
total
holdings
Voting rights
5,962,312
Percentage of voting rights 9.94689
Notes (other relevant informations according to law)
Changes due to: Dilution due to increase in number of shares
Published
05/08/2024 13:51
Contact
Phone
0709358574 Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.